This Milliman white paper examines the huge success of Wal-Mart's decision to sell a 30-day supply of some common generic drugs at just $4. As retailers become more aggressive with drug pricing, retail drug prices can vary greatly. The author recommends plan sponsors help their participants find the lowest price available for their medications, and offer incentives for doing so.